Pictured from left: John Bournas, DF Executive Director; Sewon Kang, MD, FAAD, DF Vice President; Andrew Korotzer, PhD, Regeneron; Deb Sierka, PharmD, Sanofi; Janet Fairley, MD, FAAD, DF President; Valerie M. Harvey, MD, MPH, FAAD, SOCS Immediate Past President; Jonathan Weiss, MD, FAAD, DF Board member, and Kimberly Miller, SOCS Executive Director.
The Dermatology Foundation (DF) and the Skin of Color Society (SOCS) have partnered to create and deliver an impactful opportunity to advance health equity in the specialty of dermatology.
Developed especially for the exceptional mid-career investigator with an established trajectory of excellence in basic, clinical or translational science, the Sanofi-Regeneron Diversity, Equity and Inclusion Mid-Career Award will expand the understanding of dermatological issues impacting underrepresented or underserved groups in medicine.
The Skin of Color Society and Dermatology Foundation are pleased to introduce this new mid-career award that is intended to support the work of outstanding investigators with an established trajectory of excellence in basic, clinical, or translational science. The supported research projects are expected to yield novel results that expand the understanding of dermatological issues impacting underrepresented or underserved groups in medicine.
Applications will be accepted beginning September 15 and are due on or before December 1. Watch this space for additional application details.
The Skin of Color Society (SOCS) will continue to support institution-based fellowship
opportunities with a research focus on dermatologic diseases in skin of color, particularly in
areas where further clinical, translational, and observational/
prospective research is needed. Programs with either established or emerging areas of research
focus are encouraged to apply.
Background
The ethnic and racial demographics of the United States are significantly changing. By the year
2040, people with skin of color will represent more than half of the U.S. population. There is an
increasing demand for understanding dermatologic conditions and treatments in patients with skin of
color, as well as an accompanying need for education in this growing patient population.
Given the current dermatology workforce shortage, the increased patient load has the potential to
have detrimental and adverse effects on dermatologic care for under- represented minorities.
Additional concerns include the state of dermatologic training and insufficient research involving
racial and ethnic minorities.
This transformational research has been made possible thanks to the support from the following
industry partners.
Please email the National Medical Association Dermatology Section (NMA Derm) at
Please reach out to the Skin of Color Society (SOCS) via phone at +1- 630-578-399 or email
 Valerie M. Harvey, MD, MPH, FAAD, Immediate Past President Chair |
 Cheri Frey, MD, FAAD Dermatology Section National Medical Association |
We graciously acknowledge the support from Janssen/Johnson & Johnson for this program.
Learn about Johnson & Johnson’s Our Race to Health Equity initiative here.
In recognition of the important and often groundbreaking work of the Society, we have already begun work toward 2023 goals:
Changing the face of dermatology #THX2U
